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A B S T R A C T  
Background: The aim of this study was to determine whether
an antral biopsy alone represents an adequate tissue sample
to diagnose the presence of Helicobacter pylori on the
mucosa. Furthermore, we explored the conditions associated
with the presence of H. pylori in the corpus. 
Methods: Consecutive patients who underwent an upper
gastrointestinal endoscopy at a single centre between
January 1995 and May 1997 were studied. Biopsies were
taken at each endoscopy to assess the presence of H. pylori:
two antral and two corpus biopsies for histological examina-
tion and one antral and one corpus biopsy for the CLO test. 
Results: A total of 620 patients underwent an upper gastro-
intestinal endoscopy, 307 (50%) were H. pylori infected.
In 80% of the endoscopies there was total agreement
between the performed biopsy tests. The addition of
corpus biopsies increases the diagnostic yield by 10% in
H. pylori-positive patients. Patients with only corpus
infection more often showed atrophy and intestinal meta-
plasia compared with patients with both antral and corpus
infection, 37 vs 20%, respectively (OR 2.2, 95% CI 1.1-4.4). 
Conclusion: One biopsy from the antrum or corpus seems
to be inadequate to diagnose the presence of H. pylori on
the mucosa. Patients with an infection exclusively in the
corpus more often had worse mucosa pathology.
I N T R O D U C T I O N
Helicobacter pylori is a gram-negative bacterium involved in
the pathogenesis of peptic ulcer disease, nonulcer dyspepsia,
gastric carcinoma and lymphoma.1-4 The prevalence of H.
pylori colonisation ranges from around 25% in developed
countries to over 80% in developing countries. Therefore,
diagnosis and subsequent eradication of H. pylori may be
responsible for a reduction in morbidity and mortality. 
Several invasive and noninvasive diagnostic tests can be
used to determine H. pylori status. Of all the available tests,
invasive tests (histology, culture, and rapid urease tests)
are considered the most accurate. However, there is no
established gold standard for diagnosing H. pylori status.
Invasive tests are mainly limited by their proneness to
sampling error, because of the patchy distribution of the
bacteria throughout the stomach.5,6 Furthermore, the relative
distribution of the bacteria may be altered due to the
development of gastric atrophy or metaplasia and after acid
suppression or antibiotic therapy.7-9 These circumstances
yield the possibility of false-negative results if only the
antrum or only the corpus is used as biopsy site. 
The guidelines of the European Helicobacter pylori Study
Group recommend that prior to treatment two antral
biopsies should be taken for histological examination,
for rapid urease testing, and for culture.10 The biopsy site
mentioned in these guidelines is only partly evidence based.
This is reflected by the results of several studies which
investigated the most suitable biopsy sites for histology to
detect H. pylori status. Hazell et al. found it necessary to
take antral and corpus biopsies,11 while Genta et al.
reported that it was sufficient to take only antral biopsies.12
Satoh et al. found that in their Japanese study population
it was best to take at least one corpus biopsy.13 However,
these studies were limited by relatively small patient
populations or by patient selection. As a consequence, 
it is unclear how often the presence of H. pylori on the
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mucosa may not be identified if only antral or corpus
biopsies are collected. Most endoscopists use only antral
biopsies. Therefore, the aim of this study was to examine
how many patients with H. pylori present on their mucosa
would be misdiagnosed by only taking antral biopsies for
H. pylori testing. Furthermore, we investigated in which
patients H. pylori was only present in the corpus.
M E T H O D S
Study population
The study population consisted of consecutive patients
undergoing routine upper gastrointestinal endoscopy at
the Bernhoven Hospital in Oss between January 1995 and
May 1997. All patients were symptomatic and had been
referred either to the outpatient clinic for evaluation by a
gastroenterologist, or to the open-access endoscopy by
general practitioners for diagnostic upper gastrointestinal
endoscopy. Patients were investigated by one of three
experienced endoscopists. A standard biopsy protocol,
which consisted of taking three biopsies from the antrum
and three biopsies from the corpus, was used for H. pylori
diagnosis at all times. Patients were asked not to take any
acid secretion inhibitory therapy in the week before the
upper gastrointestinal endoscopy. Patients with a history
of H. pylori eradication therapy and patients in whom not
all six test results for the presence of H. pylori were available
were excluded from the study.
Investigations
At baseline, gender and age of the patient were noted.
For each endoscopy gastrointestinal conditions and
histopathological findings were recorded by the endoscopist
and by the pathologist, respectively. Antral and corpus
biopsies were assessed for H. pylori by histological exam-
ination and by rapid urease testing. Test outcome for each
method was assessed independently from the other test
results. For histological examination, two antral and two
corpus specimens were fixed in neutral buffered 4%
formaldehyde. H. pylori identification was performed on
Giemsa-stained sections of paraffin-embedded tissue. To
measure urease activity, we performed the CLO-duo test
(Delta West, Bentley, WA, Australia), which contains two
wells. Two mucosal biopsies, one from the antrum and
one from the corpus, were placed in the two separate wells
containing the test reagent, which enabled us to document
the presence of urease activity separately for the two biopsy
sites. The reaction was analysed after 24 hours.
Data analysis
The positive or negative occurrence of H. pylori for each
of the tests was noted. Antrum and corpus were defined
as being H. pylori positive if both histology and the CLO
test were positive for antrum and corpus, respectively.
Combining H. pylori status for antrum and corpus provides
four possible outcomes. All scores were entered into a
database. Statistical analysis was carried out using 2 tests.
Unadjusted analysis for age, gender, and gastroduodenal
pathology, assessed endoscopically as well as histologically,
were calculated in order to identify factors related to the
distribution of H. pylori infection. In addition, an adjusted
regression analysis was constructed by selecting patient
characteristics found to be significantly associated with
H. pylori present only in the corpus. All analyses were
performed using SAS statistical software (SAS Institute,
Inc., Cary, NC, USA). Statistical significance was deter-
mined by p<0.05. 
R E S U L T S
A total of 620 patients underwent an upper gastrointestinal
endoscopy in which the standard biopsy protocol was
followed. The mean age of the patients (±SD) was 53 ± 
15 years; 258 (42%) were women. None of the patients
were diagnosed with gastric carcinoma, 57% had functional
dyspepsia, 20% gastroduodenal ulcers, 19% reflux
oesophagitis and in 4% other diagnosis were found. 
H. pylori infection was identified in 307 (50%) of the
patients. In 80% of the endoscopies there was total
agreement between the performed diagnostic tests for
H. pylori status (table 1). Histology of the corpus was the
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Table 1
Frequency of the different combinations of H. pylori status
for each of the biopsy tests examined in antrum and corpus
HISTOLOGY CLO TEST  HISTOLOGY  CLO TEST FREQUENCY
ANTRUM ANTRUM CORPUS CORPUS N=620 %
+ + + + 230 37.1
- - - - 268 43.2
- + + + 13 2.1
+ - + + 8 1.3
+ + - + 37 6.0
+ + + - 5 0.8
- - + + 10 1.6
- + - + 18 2.9
- + + - 0 0
+ - - + 0 0
+ - + - 2 0.3
+ + - - 4 0.6
+ - - - 1 0.2
- + - - 3 0.5
- - + - 0 0
- - - + 21 3.4
only negative test in 6%. Both histology tests were negative
and both CLO tests were positive in 3%. CLO test of the
corpus was the only positive test in 3%. 
With the chosen definition for H. pylori status in antrum
and corpus, combined antral and corpus biopsies
increased the yield compared with antral biopsies alone
by 31(5%) and compared with corpus biopsies alone by
46 (7%) (table 2). In patients with positive test results for
antrum and/or corpus H. pylori was identified from only
antral biopsies in 46 out of 307 (15%) patients, and from
only corpus biopsies in another 37 patients (10%).
Defining H. pylori status in the antrum and corpus as
positive if only one of the two tests instead of both tests
were positive resulted in more positive results.
Furthermore, changing the definition showed a considerable
decrease in the number of patients who were considered
positive for antrum and negative for corpus (from 46 to 8
patients), whereas there was no difference in the number
of patients who were considered negative for antrum and
positive for corpus (31 patients). 
Atrophy and/or intestinal metaplasia, revealed by histological
examination, were found significantly more often in the
antrum than in the corpus (18 vs 2% of all patients, respec-
tively, p<0.05). Patients with H. pylori present in only corpus
biopsies more often showed atrophy and metaplasia
compared with the other possible outcomes, 39 vs 17%,
respectively (adjusted odds ratio 3.0, 95% CI 1.4-6.1). 
D I S C U S S I O N
In current practice H. pylori detection is often based on
antral biopsies alone, as recommended by the European
Helicobacter pylori Study Group.10 Our results demonstrate
that if H. pylori status was based on only antrum biopsies,
10% of all H. pylori-positive patients would be misdiagnosed.
The addition of corpus biopsies increases the diagnostic
yield of invasive tests in a group of patients that seems to
be of great importance because of the underlying mucosa
pathology. 
A number of studies have investigated whether it is 
necessary to take both antral and corpus biopsies for the
diagnosis of H. pylori. Laine et al. reported that prior to
treatment a single antral biopsy for detection of H. pylori
provided excellent sensitivity.14 Genta et al. assessed 12
biopsy sites of the stomach for the presence of H. pylori
by histological examination and found that performing
two antral biopsies provides the detection of H. pylori in
virtually all infected patients.12 Patients having extensive
gastric atrophy with intestinal metaplasia were not
enrolled in this study. 
Our results indicate that patients with H. pylori present
only in corpus biopsies showed atrophy and intestinal
metaplasia significantly more often. This is explained by
the fact that in our study the antrum was the predominant
site for atrophy and intestinal metaplasia and the prevalence
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Table 2
Biopsy test outcomes for antrum and corpus by patient characteristics
ANTRUM + ANTRUM - ANTRUM + ANTRUM -
CORPUS + CORPUS - CORPUS - CORPUS +
N N=230 N=313 N=46 N=31
(37%) (51%) (7%) (5%)
Gender
Male 362 59% 59% 61% 48%
Female 258 41% 41% 39% 52%
Age
0< years ≤45 192 31% 32% 30% 22%
45< years <60 213 33% 36% 37% 26%
≥60 215 36% 32% 33% 52%
Macroscopic diagnosis
Peptic ulcer disease 125 33% 9% 37% 19%
Gastritis/duodenitis 215 37% 32% 43% 32%
Oesophagitis 118 14% 24% 20% 3%
Normal 137 14% 30% 7% 26%
Microscopic diagnosis
Atrophy/metaplasia in antrum 113 16% 20% 7% 35%
Atrophy/metaplasia in corpus 12 2% 2% 0% 10%
Atrophy/metaplasia 115 16% 20% 7% 39%
Biopsy site (antrum or corpus) + : both histology and CLO test give positive test results for H. pylori status at that biopsy site.
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of H. pylori decreases from gastric mucosa with atrophy
and intestinal metaplasia.7 There is considerable variation
in the prevalence of atrophy, intestinal metaplasia and
gastric cancer. Our study was performed in the Dutch
population and the results are probably applicable for the
Western population. The study by Satoh et al. was per-
formed in Japan, where the prevalence of gastric atrophy,
intestinal metaplasia and gastric cancer is much higher
compared with the Western world.13 They reported that a
corpus biopsy would be the most important site to deter-
mine H. pylori status. Therefore, the preferential biopsy
site probably depends on local prevalence of atrophy or
metaplasia. 
H. pylori infection is known to play an important role in
the development of gastric atrophy, intestinal metaplasia,15
and gastric carcinoma.3,16,17 Uemura et al. found in their
study that among patients with H. pylori infection, those
with corpus predominant gastritis, severe gastric atrophy,
and intestinal metaplasia are at particularly high risk for
gastric cancer.3 Therefore, our findings that patients with
H. pylori only present in corpus biopsies showed gastric
atrophy and intestinal metaplasia significantly more
often, suggest that patients at high risk for gastric cancer
might be misdiagnosed for H. pylori infection if only
antrum biopsies are taken. Since the antrum is the pre-
dominant site for gastric carcinoma, our finding that the
antrum showed more atrophy and intestinal metaplasia
further supports the role of H. pylori in the development
of gastric carcinoma as suggested by others.18 Although
some studies reported improvement of preneoplastic
gastric lesions after the cure of H. pylori infection,19,20
there is still debate whether eradication of H. pylori
results in regression of atrophy and intestinal metaplasia. 
A limitation of our study was that, although we asked
patients not to take acid secretion inhibitory therapy, we
did not assess whether they really did so. Especially proton
pump inhibitors are known to shift the distribution of
H. pylori proximally, and could at least in part account for
the ones with H. pylori present only in corpus biopsies.
However, when this study was performed proton pump
inhibitory therapy was a rarity before an endoscopy was
performed, quite the reverse from current practice.
Furthermore, the definition of H. pylori infection used
in this study might be disputable. For a patient to be
considered H. pylori positive at a biopsy site both tests
needed to be positive as compared with only one of the
two tests, potentially resulting in a higher occurrence of
false-negatives. However, the diagnostic yield for corpus
biopsies remained unchanged while the yield for antral
biopsies decreased considerably if only one of the tests
instead of both tests needed to be positive. This further
supports the importance of obtaining corpus biopsies.
Finally, we distinguished two categories: metaplasia present
or absent and ignored the intensity of inflammation. 
A biopsy specimen may have one goblet cell or consist
entirely of intestinal metaplasia. The extent and the grade
of metaplasia, and in particular of atrophy, are quite
important in determining the type of gastritis. 
In conclusion, the combination of antral and corpus
biopsies instead of antrum biopsies alone significantly
increases the diagnostic yield of invasive H. pylori testing.
Adequate tissue sampling results in patients being 
discovered with an infection exclusively in the corpus,
the corpus-predominant gastritis with more ominous
prognostic implications. 
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